Pharmaniaga Bhd (XKLS:7081) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 08, 2026)


XKLS:7081 Pharmaniaga Bhd XKLS:7081
46 GF Score
Price RM1.22
GF Value RM0.74
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Pharmaniaga Bhd Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Pharmaniaga Bhd's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

XKLS:7081 vs MCK, CAH, COR: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Distribution subindustry, Pharmaniaga Bhd's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmaniaga Bhd Margin of Safety % (DCF Earnings Based) vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Pharmaniaga Bhd's Margin of Safety % (DCF Earnings Based) falls into.


XKLS:7081
46GF Score
Pharmaniaga Bhd XKLS:7081
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued. The current stock price of RM1.22 is trading 64.9% above its estimated GF Value™ of RM0.74. GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.

Key valuation signals for XKLS:7081:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: RM0.74 vs. price of RM1.22 (64.9% above fair value)
  • GF Score™: 46/100 with 8 warning signs

No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmaniaga Bhd Business Description

Address No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja, Seksyen 7, Selatan, Shah Alam, SGR, MYS, 40000
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
46GF Score

Get the complete analysis for XKLS:7081

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM1.22
Price
RM0.74
GF Value